Spots Global Cancer Trial Database for stage i
Every month we try and update this database with for stage i cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Trial of AVB-620 in Women With Primary, Non-Recurrent Breast Cancer Undergoing Surgery | NCT02391194 | Breast Cancer | AVB-620 | 18 Years - | Avelas Biosciences, Inc. | |
| Post Market Study Using the Xoft Axxent System | NCT01017549 | Breast Cancer | Electronic brac... | 50 Years - | Xoft, Inc. | |
| Anti PD-1 Neo-adjuvant Treatment for NSCLC | NCT02938624 | Non Small Cell ... Stage I Stage II | Pembrolizumab 2... Pembrolizumab 2... Pembrolizumab 2... Pembrolizumab 1... Surgical resect... | 18 Years - 99 Years | Sheba Medical Center | |
| ctDNA Dynamic Monitoring and Its Role of Prognosis in Stage I NSCLS by NGS | NCT03172156 | Non-small Cell ... | ctDNA detection | 18 Years - 75 Years | Sun Yat-sen University | |
| Tamoxifen Versus Anastrozole, Alone or in Combination With Zoledronic Acid | NCT00295646 | Breast Cancer | tamoxifen anastrozole zoledronic acid goserelin | 19 Years - 59 Years | Austrian Breast & Colorectal Cancer Study Group | |
| Post Market Study Using the Xoft Axxent System | NCT01017549 | Breast Cancer | Electronic brac... | 50 Years - | Xoft, Inc. | |
| The Use of Deep Inspiration Breath Hold and Prone Irradiation to Decrease Cardiac Radiation Exposure | NCT03375892 | Breast Cancer Ductal Carcinom... Invasive Breast... | Deep Inspiratio... Free breathing ... | 18 Years - | Medical College of Wisconsin | |
| Detection of Tumor DNA in Blood Samples From Patients With Early Stage Cancer and "Healthy Controls" | NCT03071809 | Neoplasms, Non-... | 18 Years - | Lexent Bio, Inc. | ||
| MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles | NCT03053193 | Breast Cancer | MammaPrint, Blu... | 18 Years - | Agendia | |
| Adjuvant Pazopanib in Stage I NSCLC | NCT00775307 | Carcinoma, Non-... | PAZOPANIB Placebo | 18 Years - 70 Years | Intergroupe Francophone de Cancerologie Thoracique | |
| Measuring the Impact of MammaPrint on Adjuvant and Neoadjuvant Treatment in Breast Cancer Patients: A Prospective Registry | NCT02670577 | Breast Cancer | 18 Years - | Agendia | ||
| Neoadjuvant Durvalumab Alone or in Combination With Novel Agents in Resectable Non-Small Cell Lung Cancer | NCT03794544 | Resectable Early-stage NSCLC | Durvalumab Oleclumab Monalizumab Danvatirsen | 18 Years - 102 Years | MedImmune LLC | |
| Neoadjuvant Durvalumab Alone or in Combination With Novel Agents in Resectable Non-Small Cell Lung Cancer | NCT03794544 | Resectable Early-stage NSCLC | Durvalumab Oleclumab Monalizumab Danvatirsen | 18 Years - 102 Years | MedImmune LLC | |
| Patient Function/Fitness and Psychosocial Health in Improving Health-Related Quality of Life in Patients With Stage I-IV Non-Small Cell Lung Cancer | NCT02835066 | Smoking Lung Neoplasms | Integrated Fitn... Psychosocial As... Quality-of-Life... | 18 Years - | Wake Forest University Health Sciences |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
